Inspire Medical Systems, Inc. Investment Income, Interest
Inspire Medical Systems, Inc. (INSP) reported Investment Income, Interest of $34.00 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-03.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2022-05-03
- Inspire Medical Systems, Inc. investment income, interest for the quarter ending 2022-03-31 was $34.00K, a 40.35% decline year-over-year.
- Inspire Medical Systems, Inc. investment income, interest for the quarter ending 2021-12-31 was $15.00K, a 80.52% decline year-over-year.
- Inspire Medical Systems, Inc. investment income, interest for the quarter ending 2021-09-30 was $22.00K, a 82.40% decline year-over-year.
- Inspire Medical Systems, Inc. investment income, interest for the quarter ending 2021-06-30 was $31.00K, a 87.50% decline year-over-year.
- Inspire Medical Systems, Inc. investment income, interest for fiscal 2021 was $125.00K, a 88.55% decline from fiscal 2020.
- Inspire Medical Systems, Inc. investment income, interest for fiscal 2020 was $1.09M, a 71.27% decline from fiscal 2019.
- Inspire Medical Systems, Inc. investment income, interest for fiscal 2019 was $3.80M, a 103.26% increase from fiscal 2018.
- Inspire Medical Systems, Inc. investment income, interest for fiscal 2018 was $1.87M, a 821.18% increase from fiscal 2017.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2022-03-31 | $34.00K 10-Q · filed 2022-05-03 | $49.00K derived: sum of 2 quarters · filed 2022-05-03 | $71.00K derived: sum of 3 quarters · filed 2022-05-03 | $102.00K derived: sum of 4 quarters · filed 2022-05-03 |
| 2021-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $37.00K derived: sum of 2 quarters · filed 2022-02-15 | $68.00K derived: sum of 3 quarters · filed 2022-02-15 | $125.00K 10-K · filed 2022-02-15 |
| 2021-09-30 | $22.00K 10-Q · filed 2021-11-02 | $53.00K derived: sum of 2 quarters · filed 2021-11-02 | $110.00K 10-Q · filed 2021-11-02 | $187.00K derived: sum of 4 quarters · filed 2022-05-03 |
| 2021-06-30 | $31.00K 10-Q · filed 2021-08-03 | $88.00K 10-Q · filed 2021-08-03 | $165.00K derived: sum of 3 quarters · filed 2022-05-03 | $290.00K derived: sum of 4 quarters · filed 2022-05-03 |
| 2021-03-31 | $57.00K 10-Q · filed 2022-05-03 | $134.00K derived: sum of 2 quarters · filed 2022-05-03 | $259.00K derived: sum of 3 quarters · filed 2022-05-03 | $507.00K derived: sum of 4 quarters · filed 2022-05-03 |
| 2020-12-31 | $77.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $202.00K derived: sum of 2 quarters · filed 2022-02-15 | $450.00K derived: sum of 3 quarters · filed 2022-02-15 | $1.09M 10-K · filed 2022-02-15 |
| 2020-09-30 | $125.00K 10-Q · filed 2021-11-02 | $373.00K derived: sum of 2 quarters · filed 2021-11-02 | $1.01M 10-Q · filed 2021-11-02 | $1.79M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $248.00K 10-Q · filed 2021-08-03 | $890.00K 10-Q · filed 2021-08-03 | $1.67M derived: sum of 3 quarters · filed 2022-02-15 | $2.57M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $642.00K 10-Q · filed 2021-05-04 | $1.42M derived: sum of 2 quarters · filed 2022-02-15 | $2.32M derived: sum of 3 quarters · filed 2022-02-15 | $3.36M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $776.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $1.68M derived: sum of 2 quarters · filed 2022-02-15 | $2.71M derived: sum of 3 quarters · filed 2022-02-15 | $3.80M 10-K · filed 2022-02-15 |
| 2019-09-30 | $903.00K 10-Q · filed 2020-11-02 | $1.94M derived: sum of 2 quarters · filed 2020-11-02 | $3.02M 10-Q · filed 2020-11-02 | $3.85M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $1.04M 10-Q · filed 2020-08-04 | $2.12M 10-Q · filed 2020-08-04 | $2.94M derived: sum of 3 quarters · filed 2021-02-24 | $3.58M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $1.09M 10-Q · filed 2020-05-05 | $1.91M derived: sum of 2 quarters · filed 2021-02-24 | $2.55M derived: sum of 3 quarters · filed 2021-02-24 | $2.90M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $821.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.46M derived: sum of 2 quarters · filed 2021-02-24 | $1.81M derived: sum of 3 quarters · filed 2021-02-24 | $1.87M 10-K · filed 2021-02-24 |
| 2018-09-30 | $641.00K 10-Q · filed 2019-11-05 | $989.00K derived: sum of 2 quarters · filed 2019-11-05 | $1.05M 10-Q · filed 2019-11-05 | $1.13M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $348.00K 10-Q · filed 2019-08-06 | $408.00K 10-Q · filed 2019-08-06 | $492.00K derived: sum of 3 quarters · filed 2020-02-25 | $547.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $60.00K 10-Q · filed 2019-05-07 | $144.00K derived: sum of 2 quarters · filed 2020-02-25 | $199.00K derived: sum of 3 quarters · filed 2020-02-25 | $245.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $139.00K derived: sum of 2 quarters · filed 2020-02-25 | $185.00K derived: sum of 3 quarters · filed 2020-02-25 | $203.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $55.00K 10-Q · filed 2018-11-06 | $101.00K derived: sum of 2 quarters · filed 2018-11-06 | $119.00K 10-Q · filed 2018-11-06 | |
| 2017-06-30 | $46.00K 10-Q · filed 2018-08-07 | $64.00K 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $18.00K 10-Q · filed 2018-06-07 | |||
| 2016-12-31 | $57.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |